John Buckingham

Senior VP, Alliance Management, Endo Pharmaceuticals Inc.

Within two years of starting the alliance management function at Endo Pharmaceuticals, a semi-virtual US drug manufacturer and marketer with annual sales revenue of ~$600 million, the company was recognized by ASAP (Association of Strategic Alliance Professionals) in the annual ASAP Alliance Excellence Awards program, an unusual accomplishment for a company of Endo's size (previous winners included Eli Lilly, Cisco, IBM, etc.)

VP, Corporate Development, Janssen Pharmaceutical Products, LP

Completed a licensing transaction for a Phase II oncology drug, with intense competition from several large competitors with more-established oncology expertise, with less attractive financial terms than were offered by competition.

Executive Director, Global Market Development

Prepared the launch program and worked with J&J companies worldwide to introduce and build demand for recombinant human erythropoietin (EPREX, PROCRIT in the US). Led the global commercial team until global annual sales revenue surpassed US$ 1 billion, the first prescription product for the company to ever pass that milestone.

Schulich School of Business, York University

MBA

Business

University of Guelph

B, Sc. (Honours)

Microbiology, Immunology

1976

Title

Partner or Perish, `Best Practices' Lecture Series  MaRS Discovery District

2011-09-09

Partner or Perish: Implementing and Managing Effective Strategic Partnerships

A one-hour, high level overview of when and how to set up and manage key partnerships which serve to increase the efficiency and effectiveness of your venture, while reducing business risk

Setting the Table: Preparing for a Negotiation

A one-hour presentation, with audience interaction, on the elements to consider and research before sitting down at the negotiating table with a prospective collaboration partner.